EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.…
EUDA Health Subsidiary Melana International Wins Golden Bull Award 2026 Singapore
EUDA Health Holdings (NASDAQ: EUDA) is listed on Nasdaq, where its shares trade in USD. It belongs to the Real Estate Services industry, part of the Real Estate sector, and reports about 123 employees.
The shares were at 15.96 USD on 20 November 2026, down 72.9% over 52 weeks. Its 52-week range is 5.260 USD to 68.00 USD: the price is 76.5% below the high and 203.4% above the low.
Its market capitalisation is 47.79M USD.
EUDA Health Holdings reports return on equity of 65.2%, an operating margin of -28.6% and revenue up 13.4% year over year.
It holds more cash than debt, a net cash position of 25.92K USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 55.00 USD is 244.6% above the current price.
No upcoming events tracked.